drugset / Trial / NCT00321893

Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer

NCT00321893

Phase 2 Completed 225 enrolled National Cancer Institute (NCI)
RandomizedParallel-groupTriple-blindPrevention

Summary

RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of budesonide may keep lung cancer from forming in patients with lung nodules. PURPOSE: This randomized phase II trial is studying how well inhalation budesonide works in treating patients with lung nodules who are at high risk of lung cancer.

Timeline

Start
2006-01
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule 800 ug Inhaled

Indications